Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II. | Front Pharmacol | 2022 | 36483745 | PubTator, text mining | PubMed |
| Immunomodulatory regulator blockade in a viral exacerbation model of severe asthma. | Front Immunol | 2022 | 36479132 | PubTator, text mining | PubMed |
| The dual role of CD70 in B-cell lymphomagenesis. | Clin Transl Med | 2022 | 36471481 | PubTator, text mining | PubMed |
| MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response. | RNA Biol | 2022 | 36469564 | PubTator, text mining | PubMed |
| Prognostic value of PNN in prostate cancer and its correlation with therapeutic significance. | Front Genet | 2022 | 36468018 | PubTator, text mining | PubMed |
| MSC Senescence-Related Genes Are Associated with Myeloma Prognosis and Lipid Metabolism-Mediated Resistance to Proteasome Inhibitors. | J Oncol | 2022 | 36467498 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development. | Front Cell Dev Biol | 2022 | 36467412 | PubTator, text mining | PubMed |
| Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma. | Front Immunol | 2022 | 36466869 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient. | Front Immunol | 2022 | 36466840 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer. | Front Immunol | 2022 | 36466815 | PubTator, text mining | PubMed |
| Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma. | Front Oncol | 2022 | 36465363 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of the tumor ecosystem of adenoid cystic carcinoma. | Front Oncol | 2022 | 36465348 | PubTator, text mining | PubMed |
| Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications. | Hum Genomics | 2022 | 36461099 | PubTator, text mining | PubMed |
| Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer. | Biomark Res | 2022 | 36461062 | PubTator, text mining | PubMed |
| Construction and validation of a novel and superior protein risk model for prognosis prediction in esophageal cancer. | Front Genet | 2022 | 36457747 | PubTator, text mining | PubMed |
| System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer. | Aging (Albany NY) | 2022 | 36445321 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines. | Genome Med | 2022 | 36443794 | PubTator, text mining | PubMed |
| Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. | Front Oncol | 2022 | 36439494 | PubTator, text mining | PubMed |
| A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. | Front Oncol | 2022 | 36439479 | PubTator, text mining | PubMed |
| A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. | Dis Markers | 2022 | 36438905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=44